BEGIN:VCALENDAR VERSION:2.0 PRODID:-//VLAB - ECPv6.17.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://vlab.org X-WR-CALDESC:Events for VLAB REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20210314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20211107T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20220313T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20221106T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20230312T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20231105T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20221115T180000 DTEND;TZID=America/Los_Angeles:20221115T203000 DTSTAMP:20250222T054325Z CREATED:20250221T093157Z LAST-MODIFIED:20250222T054325Z UID:16358-1668535200-1668544200@vlab.org SUMMARY:Accelerating through the Turn: Which Electric Cars Will Get the Checkered Flag? DESCRIPTION:Accelerating through the Turn\nWhich Electric Cars Will Get the Checkered Flag?\n \n \n \n \n \n Tuesday\, November 15\, 2022\n6:00 pm to 8:00 pm\n(Pacific time) \n \n \n \n \n \n \n \n \n \n \n \n \n It is no secret that the global automotive landscape is undergoing a monumental transformation from internal combustion engines (ICEs) to engines using alternative\, carbon-friendly fuel sources. Perhaps the most well-known of these new automobile designs is the battery-powered electric vehicle (BEV). BEVs are being chosen to drive the future (pun intended) for several key reasons. BEVs typically have better fuel economy and lower fuel costs than ICE vehicles\, and their reduced carbon emissions can help achieve global sustainability goals. \nThe demand among consumers for BEVs continues to accelerate\, and governments have jumped on the bandwagon\, adopting new measures to reduce or eliminate the production of gas-powered vehicles. These market-shifting developments have ignited both established manufacturers and startups\, and industry leaders are placing huge bets on an all-electric future. With over 1 billion cars on the road today\, the stakes are enormous. \nUnderstandably\, these massive numbers have attracted massive amounts of capital\, and companies are scrambling to take the pole position and adopt a “BEV-first” mentality. For example\, Stellantis has invested a staggering $35 billion in the BEV space\, and Ford has invested $20 billion to facilitate the BEV transition in its product line. Large deployments of capital can also be seen on even small BEV startups\, and the transportation sector has become the fourth-largest investment sector among VCs. \nIn our upcoming VLAB panel discussion\, thought leaders\, founders\, and investors will discuss the key challenges and opportunities in the BEV space and whether legacy automakers will be quick and nimble enough to keep up with or overtake the BEV startups.\n \n\nWhat are the key challenges faced by BEV startups and incumbents?\nWhat new incentives are governments providing to help accelerate BEV adoption?\nWhich companies have the inside track in the BEV race?\n\nJoin us on November 15 to find out. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Moderators\n \n \n \n \n \n John McElroy\, Host\, Autoline Daily \nSandy Munro\, Chief Executive Officer\, Munro & Associates \n \n \n \n \n \n Panelists\n \n \n \n \n \n Chris Anthony\, Chief Executive Officer\, Aptera \nVolker Kaeser\, Chief Technology Officer\, Indigotech \nAlexei Andreev\, Managing Director\, Autotech Ventures\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Free Online Event \n \n \n \n \n \n \nA Note about Ticket Sales \n\n\nWe understand that many people may be having a rough time during the COVID-19 pandemic. Therefore\, the tickets for this online event will be offered free of charge to anyone who is interested in attending. \nNormally\, ticket sales are our main source of revenue\, so VLAB could really use your support. When you register for the event\, please consider making a donation to help keep VLAB going. \nVLAB is a registered 501(c)(3) non-profit organization\, and any help you could provide would be greatly appreciated. We thank you for your support and hope to see you soon. URL:https://vlab.org/event/bevs/ LOCATION:Online Event CATEGORIES:VLAB Panel ATTACH;FMTTYPE=image/jpeg:https://vlab.org/wp-content/uploads/2022/11/VLAB-BEVs.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20231205T180000 DTEND;TZID=America/Los_Angeles:20231205T203000 DTSTAMP:20250707T200445Z CREATED:20250219T094204Z LAST-MODIFIED:20250707T200445Z UID:16051-1701799200-1701808200@vlab.org SUMMARY:Fully Homomorphic Encryption: Is FHE the Holy Grail for Security? DESCRIPTION:Fully Homomorphic Encryption\nIs FHE the Holy Grail for Security?\n \n \n \n \n \n Tuesday\, December 5\, 2023 \n6:00 pm to 8:30 pm\n6:00 pm: Reception and networking\n7:00 pm: Panel discussion (with Q&A) \n \n \n \n \n \n Fully Homomorphic Encryption (FHE)\, widely recognized as one the most secure encryption methods in cryptography\, has recently seen major breakthroughs that could unlock FHE’s true potential. \nFHE is a powerful cryptographic algorithm that allows trusted parties to work with encrypted data without the need of first decrypting the data. This means that organizations can view\, process\, and analyze data without compromising the security of that data. This capability could solve key problems and create new opportunities across a wide range of applications\, such as healthcare\, finance\, artificial intelligence (AI)\, and other industries that manage highly sensitive data. \nEven though the first feasible FHE scheme was proposed back in 2009\, the ability to deploy FHE effectively has been limited by the processing power of existing hardware. Now in its fourth generation\, recent advances in both software and hardware have triggered a new race among R&D centers and startups to apply FHE architecture to cloud services and other applications. \nUsing FHE to protect data in virtual environments could unlock billions of dollars in business potential in data privacy-challenged applications. Other encryption methods — such as secure-enclaves\, or zero-knowledge proof — simply cannot provide the same level of security and flexibility as FHE. \nIn our upcoming VLAB panel discussion\, thought leaders\, founders\, and investors will discuss the latest developments in FHE: \n\nWhich players are leading the race to be the first to provide FHE solutions?\nWhat are the potential risks and challenges associated with FHE?\nDoes FHE truly have the potential to be the holy grail of encryption?\n\nJoin us on December 5 to learn more about FHE. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Moderator\n \n \n \n \n \n Brett Hartman\, Lecturer\, California Polytechnic State University \n \n \n \n \n \n Panelists\n \n \n \n \n \n Jorge Myszne\, Chief Product Officer\, Niobium Microsystems \nMache Creeger\, Vice President Business Development\, Cornami \nEric Ball\, Founding General Partner\, Impact Venture Capital URL:https://vlab.org/event/fully-homomorphic-encryption-is-fhe-the-holy-grail-for-security/ LOCATION:Los Altos Community Center\, 97 Hillview Avenue\, Los Altos\, CA\, 94022\, United States CATEGORIES:VLAB Panel ATTACH;FMTTYPE=image/jpeg:https://vlab.org/wp-content/uploads/2023/10/VLAB-FHE.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250320T183000 DTEND;TZID=America/Los_Angeles:20250320T210000 DTSTAMP:20250707T213121Z CREATED:20250213T184800Z LAST-MODIFIED:20250707T213121Z UID:15193-1742495400-1742504400@vlab.org SUMMARY:The Future of Drug Discovery: Is Generative AI the Next Breakthrough in Drug Design? DESCRIPTION:The Future of Drug Discovery\nIs Generative AI the Next Breakthrough in Drug Design?\n \n \n \n \n \n Tuesday\, April 15\, 2008\n6:00 pm to 8:30 pm\n6:00 pm: Reception and networking\n7:00 pm: Panel discussion (with Q&A) \n \n \n \n \n \n \nBuy Tickets on Eventbrite\n\nPurchase Tickets\n\n\n\n\n \n \n \n \n \n \nBuy Tickets on Eventbrite\n\nPurchase Tickets\n\n\n\n\n \n \n \n \n \n New drugs have revolutionized healthcare\, with over 200 novel therapeutics gaining FDA approval over the past five years. One key aspect to product success has been – and will continue to be – finding the right drug to bring into development\, as up to 85% of new synthetic chemical compounds fail to reach the market. Traditionally\, drug candidates have been vetted using a process called high-throughput screening (HTS)\, where thousands of drug candidates are evaluated through their reactivity with specific biological targets. The hit rate of HTS\, however\, can be quite low\, with some estimates at significantly less than 0.01 percent. \nNew Generative AI promises to transform drug discovery through new approaches to identifying drug candidates. By leveraging recent innovations in AI\, companies have mined databases to discover new drug-target interactions or design novel compounds. These revolutionary advances are accelerating the development of treatments for cancers and other complex diseases\, improving patient outcomes and reducing healthcare costs. For both startups and established companies\, this represents an unprecedented opportunity to reshape the future of drug development. \nNew Featuring pharmaceutical executives\, biotech entrepreneurs\, and AI innovators\, our event panel will explore whether AI is truly a breakthrough in drug discovery\, and how it can address long-standing challenges in the industry. \n\nWhat are the key approaches to using Generative AI to invent new drug candidates?\nWhat challenges and limitations remain in AI-driven drug discovery?\nHow can startups navigate FDA evaluation of AI-driven drug discovery approaches?\nHow are pharmaceutical companies and startups collaborating to accelerate AI-driven innovation around drug discoveries?\n\nNew Join us on March 20 to peer into the future of drug discovery. \n \n \n \n \n \n \nBuy Tickets on Eventbrite\n\nPurchase Tickets\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Moderator \n \n \n \n \n \n \n \n \n \n \n \n AaronArvey\nHead of Computational Discovery\, Third Rock Ventures\n \n \n \n \n \n \n \n \n \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n Panelist \n \n \n \n \n \n \n \n \n \n \n \n PetrinaKamya\nVice President & Global Head of AI Platforms\, Insilico Medicine\n \n \n \n \n \n \n \n \n \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n Panelist \n \n \n \n \n \n \n \n \n \n \n \n VenkateshMysore\nChief Technology Officer and Co-Founder\, Aikium\n \n \n \n \n \n \n \n \n \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n Panelist \n \n \n \n \n \n \n \n \n \n \n \n DavidSolow-Cordero\nAssociate Director\, High Throughput Screening Knowledge Center & Innovative Medicine Accelerator (IMA)\, Stanford University\n \n \n \n \n \n \n \n \n \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n Panelist \n \n \n \n \n \n \n \n \n \n \n \n LuWang\nInvestment Director\, Foothill Ventures\n \n \n \n \n \n \n \n \n \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Ticket Includes Food and Drink \n \n \n \n \n \n View or download flyer for event: \n \n \n \n \n \n \n \n \n \n \n \n Download printable PDF. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n \n View Page on Eventbrite\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Special Thanks to Our Event Sponsors URL:https://vlab.org/event/future-of-drug-discovery/ LOCATION:SVB Experience Center\, 532 Market Street\, San Francisco\, CA\, 94104\, United States CATEGORIES:VLAB Panel ATTACH;FMTTYPE=image/jpeg:https://vlab.org/wp-content/uploads/2025/01/Future-of-Drug-Discovery.jpg END:VEVENT END:VCALENDAR